The department supports investigator-led research through a series of well-founded laboratories. This research covers every aspect of biological science related to medicine: from the bench to the bedside, from blue sky to full clinical trials, from technology development to spin-out. It covers many fields and many clinical disciplines.
The department supports this research in an environment designed to foster the long-term career development of fellows and research staff.
All of the above is made possible through the generosity and long-term support of our sponsors and funders.
A specialist technique used to study drugs has been completed for the first time during an outbreak of Ebola virus disease. This study used pharmacokinetics – the measurement of the change in drug concentration in a person over time – to study an experimental drug for the treatment of Ebola virus disease during the 2015 outbreak in Sierra Leone.
United Nations sustainable development goals aim for the elimination of viral hepatitis as a public health threat by 2030, leading to efforts to upscale the availability and accessibility of hepatitis B virus (HBV) vaccination, diagnosis, and treatment globally. Philippa Matthews and co-researchers set out to investigate how HBV is understood and described in communities in Uganda, and whether there is evidence of potential stigma.